These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6295108)

  • 1. Lysosomal enzymes and metabolic activity of polymorphonuclear leukocytes from patients with systemic lupus erythematosus and from experimental animals after levamisole treatment.
    Ferencík M; Rovenský J; Stefanovic J
    Agents Actions; 1982 Oct; 12(4):478-84. PubMed ID: 6295108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of growth hormone on the activity of some lysosomal enzymes in neutrophilic polymorphonuclear leukocytes of hypopituitary dwarfs.
    Rovenský J; Ferencíková J; Vigas M; Lukác P
    Int J Tissue React; 1985; 7(2):153-9. PubMed ID: 2993187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of levamisole on lysosomal enzyme release from polymorphonuclear leukocytes and intracellular levels of cAMP and cGMP after phagocytosis of monosodium urate crystals.
    Mikulíková D; Trnavský K
    Agents Actions; 1980 Sep; 10(4):374-7. PubMed ID: 6255776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of myeloperoxidase in respiratory burst of human polymorphonuclear leukocytes. Studies with myeloperoxidase-deficient subjects.
    Dri P; Soranzo MR; Cramer R; Menegazzi R; Miotti V; Patriarca P
    Inflammation; 1985 Mar; 9(1):21-31. PubMed ID: 2984121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal enzymes and superoxide production in polymorphonuclear leukocytes of patients with primary varicose veins.
    Stvrtinová V; Ferencíková J
    Cor Vasa; 1992; 34(3):255-64. PubMed ID: 1339112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent regulation of leukotriene B4-elicited polymorphonuclear leukocyte exocytosis and superoxide generation by a serum factor.
    Mandell BF
    J Leukoc Biol; 1987 Apr; 41(4):318-24. PubMed ID: 3033108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of levamisole on the phagocytic function of polymorphonuclear neutrophils from patients with systemic lupus erythematosus.
    Demin AA; Drobysheva VP
    J Immunopharmacol; 1980; 2(2):279-83. PubMed ID: 6821554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.
    Fantone JC; Marasco WA; Elgas LJ; Ward PA
    Am J Pathol; 1984 Apr; 115(1):9-16. PubMed ID: 6324595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of zymosan-induced release of lysosomal enzymes from human polymorphonuclear leukocytes by cytochalasin B.
    Skosey JL; Damgaard E; Chow D; Sorensen LB
    J Cell Biol; 1974 Sep; 62(3):625-34. PubMed ID: 4853241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of phagocytosis and lysosomal enzyme release from human leukocytes by serum from patients with systemic lupus erythematosus.
    Zurier RB
    Arthritis Rheum; 1976; 19(1):73-8. PubMed ID: 1252270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The releasability of lysosomal enzymes from neutrophil leukocytes in patients with rheumatoid arthritis.
    Marinò I; Columbo M; Marone G
    Clin Exp Rheumatol; 1996; 14(4):387-94. PubMed ID: 8871837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Levamisole and its effect on the release of lysosomal enzymes from human polymorphonuclear leucocytes (author's transl)].
    Mikulíková D; Trnavský K
    Cas Lek Cesk; 1982 Jan; 121(4):112-5. PubMed ID: 7060065
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus.
    Ren Y; Tang J; Mok MY; Chan AW; Wu A; Lau CS
    Arthritis Rheum; 2003 Oct; 48(10):2888-97. PubMed ID: 14558095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes.
    Winberg LK; Jacobsen S; Nielsen CH
    Arthritis Res Ther; 2017 Oct; 19(1):230. PubMed ID: 29041967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of levamisole (LMS) on lysosomal enzyme release and receptors of polymorphonuclear leukocytes].
    Hayashi Y
    Showa Shigakkai Zasshi; 1987 Mar; 7(1):31-6. PubMed ID: 3505081
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased superoxide production by polymorphonuclear leukocytes in systemic lupus erythematosus.
    Casellas AM; Prat A; Llera A; Manni J; Boveris A; Sarano JF
    Clin Exp Rheumatol; 1991; 9(5):511-4. PubMed ID: 1659509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of arachidonic acid and of phospholipase A2 in the control of lysosomal enzyme release from human polymorphonuclear leukocytes.
    Marone G; Fimiani B; Torella G; Poto S; Bianco P; Condorelli M
    J Clin Lab Immunol; 1983 Oct; 12(2):111-6. PubMed ID: 6644791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of local anesthetics upon human polymorphonuclear leukocyte function in vitro. Reduction of lysosomal enzyme release and superoxide anion production.
    Goldstein IM; Lind S; Hoffstein S; Weissmann G
    J Exp Med; 1977 Aug; 146(2):483-94. PubMed ID: 195003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The release of lysosomal enzymes from human polymorphonuclear leukocytes by human C3e.
    Ghebrehiwet B
    Clin Immunol Immunopathol; 1984 Feb; 30(2):321-9. PubMed ID: 6198120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anti-rheumatic drugs on the release of lysosomal enzymes from human leukocytes.
    Wildfeuer A
    Z Rheumatol; 1984; 43(1):23-6. PubMed ID: 6324512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.